Coliseum Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001409751

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedConsumer TiltHigh Turnover how tags are computed

Q2 2024 · 14 positions · Total reported value $1.12B · Top-10 concentration 94.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 1 new · 1 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -19.2% · vs SPY -21.4% · Prev Value $1.16B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.5% · vs SPY +3.3% · Latest Value $982.93M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Coliseum Capital Management, LLC disclosed 14 equity positions with a combined reported value of $1.12B. The filing implies a focused portfolio: its ten largest positions account for 94.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were GIL ($385.22M), UTI ($146.83M), RCM ($129.17M). By sector, the heaviest allocations are Consumer Discretionary 39.6%, Real Estate 13.1%. Versus the prior quarter, allocation shifted toward Industrials (+2.6pp), Other (+1.7pp) and away from Real Estate (-0.6pp), Health Care (-1.5pp).

Versus the prior quarter, Coliseum Capital Management, LLC opened 1 new positions, trimmed 1 and fully exited 1, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q2 2024 were WSC ($18.58M), CDMO ($12.47M), USFD ($9.83M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • WSC WILLSCOT HLDGS CORP · $18.58M
  • CDMO AVID BIOSERVICES INC · $12.47M
  • USFD US FOODS HLDG CORP · $9.83M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Coliseum Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-08 Sell UNIVERSAL TECHNICAL INSTITUTE INC 3,000,000 $41.40 SEC filing

All insider transactions →

Fund Profile

Coliseum Capital Management, LLC is an SEC-registered 13F filer based in Rowayton, CT, United States. As of Q3 2026 it reported 11 US equity positions with a combined value of $982.93M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: ROWAYTON, CT, United States
  • SEC registration: 801-74175 (status: Approved), registered 2012-03-27
  • Regulatory AUM (Form ADV): $2.27B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds

Portfolio Structure

  • 11 positions · $982.93M reported value (Q3 2026)
  • Top 10 holdings = 99.6% of reported value
  • Largest position: SONO (SONOS INC) at 32.9%
  • Average position size: $89.36M

Sector Tilt

  • Consumer Staples 33.5%
  • Industrials 32.3%
  • Consumer Discretionary 31.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 new, 5 added, 1 reduced, 1 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Real Estate 13.1%
Other 27.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 10.16M $385.22M 34.34%
34.34%
Add
2 9.33M $146.83M 13.09%
13.09%
Hold
3 10.28M $129.17M 11.51%
11.51%
Hold
4 2.98M $78.27M 6.98%
6.98%
Hold
5 944.47K $76.13M 6.79%
6.79%
Add
6 4.68M $69.05M 6.16%
6.16%
Add
7 3.37M $63.68M 5.67%
5.67%
Add
8 46.86M $48.73M 4.34%
4.34%
Hold
9 1.94M $45.27M 4.04%
4.04%
Add
10 4.47M $22.16M 1.98%
1.98%
Hold
11 493.62K $18.58M 1.66%
1.66%
New
12 6.52M $16.57M 1.48%
1.48%
Hold
13 1.75M $12.47M 1.11%
1.11%
New
14 185.60K $9.83M 0.88%
0.88%
New

FAQ

What did Coliseum Capital Management, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, Coliseum Capital Management, LLC reported 14 equity positions worth $1.12B in aggregate; its largest disclosed positions were GIL ($385.22M), UTI ($146.83M), RCM ($129.17M).

How large is Coliseum Capital Management, LLC's portfolio?

Coliseum Capital Management, LLC reported $1.12B of long equity holdings across 14 positions as of 2024-Q2. Top-10 holdings account for 94.9% of reported value.

What is Coliseum Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/coliseum-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →